Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04134624 · ClinicalTrials.gov registry record · NA
EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock
A NA study, sponsored by HealthPartners Institute.
- Terminated
- Registry status
- NA
- Development phase
- 215
- Enrollment target
NCT04134624 is a NA study that was terminated before completion, run by HealthPartners Institute. The registered enrollment target is 215 participants.
The verdict
NCT04134624, a NA study, was terminated before completion, sponsored by HealthPartners Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 215 participants
- Enrollment target
Study Summary
This study is designed to improve the outcomes for patients suffering from severe sepsis and septic shock (SS/SS) by decreasing the time from first medical contact to antibiotic administration. This is a stepwise study that aims to demonstrate the ability of paramedics to accurately obtain blood cultures prior to hospital arrival, administer a broad spectrum antibiotic and initiate IV fluid resuscitation in patients meeting predefined criteria for SS/SS.
Interventions
- OTHER Sepsis care bundle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2021-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04134624
The ClinicalTrials.gov registry entry for NCT04134624 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sepsis care bundle is the first listed.
NCT04134624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04134624 about?
NCT04134624 is a clinical study titled "EMS Prehospital Blood Culture Collection and Antibiotic Administration: A Two-Phase Pilot Project to Reduce Mortality in Patients With Severe Sepsis and Septic Shock". This study is designed to improve the outcomes for patients suffering from severe sepsis and septic shock (SS/SS) by decreasing the time from first medical contact to antibiotic administration. This is a stepwise study that aims to demonstrate the ability of paramedics to accurately obtain blood cul...
What is the current status of trial NCT04134624?
This trial is currently terminated. It is a NA study. The enrollment target is 215 participants. The study started on 2019-09-11. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT04134624?
The interventions under investigation include: Sepsis care bundle (OTHER).
Who is sponsoring clinical trial NCT04134624?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.